Skip to main content

Home
About Reactiv8
For Clinicians
About Mainstay
News & Events
Investors
Careers
Contact Us

EN
FR
DE
NL
US
AU

Sub menu▸

OVERVIEW
Results and Presentations
News
Governance
Share Price
Shareholder Information
Rule 26 Information
Contact Us

Listing Documents

Documents relating to the initial public offering of Mainstay Medical International plc.

Intention to Float Announcement
Indicative Price Range Announcement
Pre-Admission Announcement - ESM Schedule One
Total Number of Shares and Voting Rights Announcement
Prospectus
French convenience translation of the Prospectus and further step in 2014 corporate reorganisation announcement
Pricing Statement
Pricing Release
Partial Exercise of the Over-Allotment Option

© Copyright 2017 Mainstay Medical Limited. All rights reserved.

Footer menu

Site Map
Contact Us
Impressum
Privacy Policy
Terms & Conditions
Commercial Terms & Conditions

ReActiv8 is CE marked for the treatment of chronic low back pain and available for sale in Europe.

Disclaimer

I am in the United States, Canada, Japan or Australia.

Show